Horstmeier Paul 4
4 · Health Catalyst, Inc. · Filed Apr 14, 2022
Insider Transaction Report
Form 4
Horstmeier Paul
Chief Operating Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-04-12−4,167→ 35,402 totalExercise: $15.84Exp: 2029-02-05→ Common Stock (4,167 underlying) - Exercise/Conversion
Common Stock
2022-04-12$10.80/sh+521$5,627→ 185,524 total - Exercise/Conversion
Common Stock
2022-04-12$15.84/sh+4,167$66,005→ 185,003 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-12−521→ 18,474 totalExercise: $10.80Exp: 2028-09-27→ Common Stock (521 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2022-04-12−520→ 5,728 totalExercise: $15.84Exp: 2029-02-05→ Common Stock (520 underlying) - Sale
Common Stock
2022-04-12$25.16/sh−5,208$131,045→ 180,316 total - Exercise/Conversion
Common Stock
2022-04-12$15.84/sh+520$8,237→ 180,836 total
Footnotes (4)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1.
- [F2]25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
- [F3]25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.
- [F4]25% of the 18,995 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.